Investigation Overview
Company
Security
NASDAQ: XOMA
Summary
An investigation on behalf of investors in shares of XOMA Corporation (NASDAQ:XOMA) was announced over potential breaches of fiduciary duties by certain officers and directors at XOMA.
The investigation by a law firm concerns whether certain XOMA directors breached their fiduciary duties and caused damage to the company and its shareholders.
Emeryville, CA based XOMA Corporation is a development-stage biotechnology company that focuses on the discovery and development of monoclonal antibody-based therapeutic. XOMA Corporation reported that its annual Total Revenue declined from $55.45 million in 2015 to $5.56 million in 2016 and that its Net Loss increased from $20.61 million in 2015 to $53.53 million in 2016.